Literature DB >> 1291649

The microcirculation and hypertension.

H A Struijker Boudier1, J L le Noble, M W Messing, M S Huijberts, F A le Noble, H van Essen.   

Abstract

AIM: To review published evidence on the effects of arteriolar changes in primary and secondary hypertension.
BACKGROUND: Pressure profile analyses have shown that the microcirculation is a major site of vascular resistance. With the recent refinement of intravital microscopy techniques detailed information has become available on mechanisms of the microvascular resistance increase in hypertension. Three mechanisms play an important role: (1) a decrease in arteriolar diameter; (2) arteriolar vessel wall hypertrophy; and (3) small arteriolar and capillary rarefaction.
METHOD: The evidence was synthesized into a hypothesis on the role of the microcirculation in primary forms of hypertension. HYPOTHESIS: The hypothesis formulated contains two important elements in that (1) diminished outgrowth of the microvascular bed in different tissues is seen as an important early pathogenic mechanism; and (2) the decreases in arteriolar diameter and vessel wall hypertrophy are seen as adaptive mechanisms that maintain a constant wall stress. The three factors together maintain the increase in vascular resistance that is common to all established forms of primary hypertension.

Entities:  

Mesh:

Year:  1992        PMID: 1291649

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  18 in total

1.  Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension.

Authors:  T F T Antonios; F M Rattray; D R J Singer; N D Markandu; P S Mortimer; G A MacGregor
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

2.  Vascular mechanisms of cyclosporin-induced hypertension in the rat.

Authors:  J B Roullet; H Xue; D A McCarron; S Holcomb; W M Bennett
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  Brain capillary perfusion in the spontaneously hypertensive rat during the wake-sleep cycle.

Authors:  Alessandro Silvani; Tijana Bojic; Tullia Cianci; Carlo Franzini; Pierluigi Lenzi; Maria Luisa Lucchi; Giovanna Zoccoli
Journal:  Exp Brain Res       Date:  2003-09-06       Impact factor: 1.972

4.  Plasma lactate and incident hypertension in the atherosclerosis risk in communities study.

Authors:  Stephen P Juraschek; Julie K Bower; Elizabeth Selvin; Ghanshyam Palamaner Subash Shantha; Ron C Hoogeveen; Christie M Ballantyne; J Hunter Young
Journal:  Am J Hypertens       Date:  2014-07-03       Impact factor: 2.689

5.  Mevalonate availability affects human and rat resistance vessel function.

Authors:  J B Roullet; H Xue; C M Roullet; W S Fletcher; M J Cipolla; C T Harker; D A McCarron
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 6.  Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib.

Authors:  C Porta; C Paglino; I Imarisio; L Bonomi
Journal:  Clin Exp Med       Date:  2008-01-11       Impact factor: 3.984

Review 7.  The role of exercise in the reversal of IGF-1 deficiencies in microvascular rarefaction and hypertension.

Authors:  Amani M Norling; Adam T Gerstenecker; Thomas W Buford; Bilal Khan; Suzanne Oparil; Ronald M Lazar
Journal:  Geroscience       Date:  2019-12-05       Impact factor: 7.713

8.  Cerebral blood flow and cognitive function in patients with metabolic syndrome: effect of antihypertensive therapy.

Authors:  Irina Efimova; Natalya Efimova; Yuri Lishmanov
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-10       Impact factor: 3.738

9.  Challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancer.

Authors:  Maria E Cabanillas; Mimi I Hu; Jean-Bernard Durand; Naifa L Busaidy
Journal:  J Thyroid Res       Date:  2011-10-04

10.  Perivascular Fat and the Microcirculation: Relevance to Insulin Resistance, Diabetes, and Cardiovascular Disease.

Authors:  A J Houben; E C Eringa; A M Jonk; E H Serne; Y M Smulders; C D Stehouwer
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.